AzTrials
AzTrials

Heat IntoleranceATHENANCT05678738

Acquiring and Targeting Heat Exposures Necessary for Action

A study testing Antioxidant Berry Supplementation and Acute and Chronic Exercise-Heat Stress in people with Heat Intolerance and Heat Stress, run by University of Connecticut at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Heat Intolerance, Heat Stress, Fatigue; Heat
What is being tested?
Antioxidant Berry Supplementation and Acute and Chronic Exercise-Heat Stress
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
108 participants
Where
1 siteUnited States
Study dates
16 Sep 2021to 17 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Participants will be healthy men and women, aged 18-50 years, who speak and read the English language fluently. This is required because some of the cognitive tests test grammatical reasoning and offer directional cues recorded as audio files in English. VO2max tests will provide evidence of level of aerobic fitness required to participate in this study. The investigators will use ≥45 ml·kg-1·min-1 for male participants, ≥40 ml·kg-1·min-1 for female participants as our threshold for inclusion.
  • The target composition of our subject sample is 50% men and 50% women.
  • No difficulties with vision, hearing, or ability to read a computer screen and operate a computer keyboard and mouse.

Who cannot join

  • unable to visit the laboratory on the required, consistent schedule and consecutive required days (Days 2 and 3, Days 12 and 13)
  • any contraindications to participating in exercise lasting 60-120 minutes daily during a period of 2 consecutive days, 5 days within an 8-day period, and 2 additional days (if subjects elect to participate in the entire study, all options), screening will include resting blood pressure to exclude pre-hypertensive or hypertensive participants (resting BP > 120 mmHg and 80mmHg systolic and diastolic, respectively)
  • any contraindications to exposure to exercise-heat stress (e.g., medications that affect thermoregulation, family or personal history of issues with anesthetics that indicate possible susceptibility to malignant hyperthermia, evidence of past heat intolerance)
  • tobacco use or electronic cigarettes (e-cigarettes) within the past 6 months
  • chronic illness (including diabetes, metabolic syndrome, thyroid disease, for example) or other chronic illnesses that make it unsafe for participants to participate in daily rigorous exercise in the heat
  • regular supplementation with blood thinners, including the use of aspirin
Show all 19Show fewer
  • acute illness (e.g., influenza, head cold, gastrointestinal illness) during the week of scheduled testing
  • current positive COVID-test or infection and past COVID infection within past 6 months
  • contraindications to blood draw and if elected to be considered for participation with microdialysis and skeletal muscle biopsy procedures, contraindications to those individual procedures
  • for subjects who may not complete a DXA scan, history of claustrophobia
  • history of allergic reactions to medical tape and/or latex
  • currently participating in "non-traditional" diets including diets such as intermittent fasting, caloric restriction, highly limited consumption of large food classes (e.g., vegan)
  • consumption of antioxidant supplementation on a regular, long-term basis outside of the aronia supplementation regime for the study
  • limited decision-making ability
  • inability to participate in extended physical activity on a treadmill (i.e., standing, running, jogging, walking)
  • consumption of a non-traditional diet including diets such as intermittent fasting, caloric restriction, highly limited consumption of large food classes (e.g., vegan) (this includes individuals who are suffering with current diagnosed or undiagnosed eating disorder)
  • allergy to povidone, ethyl chloride, lidocaine, or bacitracin
  • pregnant or positive pregnancy test during DXA pre-procedures (see DXA SOP)
  • allergy to aronia berries, monkfruit, or sham juice ingredients

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Human Performance Laboratory at the University of Connecticut

    Storrs, Connecticut, 06269

Other trials in United States

About this study

Official title: Enhancing Lethality by Targeting Cognitive and Physiological Mechanisms of Female Warfighter Resiliency to Consecutive Days of Intense Exercise in the Heat

The purpose of this research study is to better understand ways that women and men differ physiologically, cognitively, physically, and cellularly to better prescribe helpful interventions that will prevent injury and risk of conditions like exertional heat illnesses or heatstroke. The main questions this project aims to answer are:

  1. What is the relative stress contributing to performance differences between women and men during intense exercise in extremely hot and humid environments in response to exertional heat stress?
  2. What is the relative contribution of responses in adipose tissue, cardiovascular tissue, gut microbiota, and musculoskeletal tissue on heat tolerance in women (vs. men) to exertional heat stress?
  3. What is the impact of adding an antioxidant juice consumption regime and will it assist in enhancing performance during an acute bout of exercise-heat stress before and after heat acclimation?
Read more

Subjects enrolled and approved for participation will perform:

  1. a heat acclimation protocol which includes the completion of 5 days of prescribed exercise-heat exposure
  2. two separate acute exercise-heat exposures for the assessment of thermotolerance and the investigation of potential enhancements in thermoregulatory performance that may occur after the completion of a 5-day heat acclimation protocol
  3. a subset of subjects enrolled and approved for participation who opt in to antioxidant berry supplement consumption will either consume the active or placebo product throughout their participation.
Being tested
Antioxidant Berry Supplementation, Acute and Chronic Exercise-Heat Stress, Placebo (non-juice) Supplementation
Keywords
Sex Differences, Physical Performance, Body Composition, Heat Acclimation
Medical subject headings
Heat Stress Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Antioxidant Berry SupplementationDietary supplement

    Participants who opt-in will be instructed to consume 300mL of the bioactive (antioxidant berry) supplement every morning and afternoon during days of participation.

  • Acute and Chronic Exercise-Heat StressOther

    All participants (male and female) will be exposed to repeated bouts of exercise-heat stress.

  • Placebo (non-juice) SupplementationDietary supplement

    Participants who opt-in will be instructed to consume 300mL of the placebo (non-juice) supplement every morning and afternoon during days of participation.

Study groups in NCT05678738
Study groupRoleWhat they receive
Acute and Chronic Exercise-Heat StressExperimentalAll participants (male and female) will be exposed to repeated bouts of exercise-heat stress.
Receives: Other: Acute and Chronic Exercise-Heat Stress
Exercise-Heat Stress + Antioxidant Berry SupplementationActive comparatorAll participants (male and female) will be exposed to repeated bouts of exercise-heat stress. Participants who opt-in may be randomly assigned to receive bioactive (antioxidant berry supplement) ingredient in addition to repeated bouts of exercise-heat stress.
Receives: Dietary Supplement: Antioxidant Berry Supplementation; Other: Acute and Chronic Exercise-Heat Stress
Exercise-Heat Stress + Placebo (Non-juice) SupplementationPlacebo comparatorAll participants (male and female) will be exposed to repeated bouts of exercise-heat stress. Participants who opt-in may be randomly assigned to receive placebo (non-juice) ingredient in addition to repeated bouts of exercise-heat stress.
Receives: Other: Acute and Chronic Exercise-Heat Stress; Dietary Supplement: Placebo (non-juice) Supplementation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Rectal Temperature at Rest

    Rectal thermometer will be self-inserted by participants to assess core temperature prior to exercise-heat stress bouts

    Measured: Through study completion, an average of 14 days

  2. Change in Rectal Temperature Rate of Rise

    Rectal thermometer will be self-inserted by participants to assess core temperature during exercise-heat stress bouts

    Measured: Through study completion, an average of 14 days

  3. Change in Rectal Temperature at Thermal Threshold (38.5C)

    Rectal thermometer will be self-inserted by participants to assess core temperature during exercise-heat stress bouts at the thermal threshold of 38.5C

    Measured: Measured throughout 5 90-minute exercise-heat stress bouts (heat acclimation sessions)

  4. Change in Mean Skin Temperature

    Prior to start of exercise, participants will be instrumented with iButton skin temperature sensors on the chest, shoulder, abdomen, neck, back, thigh, and calf

    Measured: Through study completion, an average of 14 days

  5. Change in Heart Rate

    A heart rate monitor will be worn by participants throughout the exercise-heat stress bouts

    Measured: Through study completion, an average of 14 days

  6. Change in Heart Rate at Thermal Threshold (38.5C)

    A heart rate monitor will be worn by participants throughout the exercise-heat stress bouts to assess HR at the thermal threshold of 38.5C

    Measured: Measured throughout 5 90-minute exercise-heat stress bouts (heat acclimation sessions)

  7. Change in Whole Body Sweat Rate

    Difference in body weight measurement measured prior to and at the cessation of each exercise-heat stress bout

    Measured: Measured at the beginning and end of 5 90-minute exercise-heat stress bouts (heat acclimation sessions)

  8. Change in Sweat Metabolite and Protein Expression

    Sweat samples will be collected and assessed for metabolite and protein expression discovery via mass spectrometry

    Measured: Measurement completed during each exercise-heat stress bout (Heat Tolerance Tests 1 [days 5 and 12] and 2 [days 6 and 13]) both before and immediately after heat acclimation as well as the final heat acclimation session (HA5 - day 11)

  9. Change in Cognitive Measures - Visual Vigilance

    Participants will perform an assessment of visual vigilance through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  10. Change in Cognitive Measures - Psychomotor Vigilance

    Participants will perform an assessment of psychomotor vigilance through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  11. Change in Cognitive Measures - Four Choice Task

    Participants will perform an assessment of four choice task success through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  12. Change in Cognitive Measures - Match to Sample

    Participants will perform an assessment of match to sample success through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  13. Change in Cognitive Measures - Repeated Acquisition

    Participants will perform an assessment of repeated acquisition through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  14. Change in Cognitive Measures - Grammatical Reasoning

    Participants will perform an assessment of grammatical reasoning through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  15. Change in Cognitive Measures - Profile of Mood States

    Participants will perform an assessment of profile of mood states through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  16. Change in Cognitive Measures - Stroop Task

    Participants will perform an assessment of stroop task success through a validated computer programming system. The test is part of a larger Testing battery which should take approximately 30 minutes for completion

    Measured: Measurement completed immediately after one exercise-heat stress bout (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  17. Change in Physical Performance - Anaerobic Performance

    Participants will be assessed for anaerobic performance with the completion of a 400 meter sprint for time. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  18. Change in Physical Performance - Agility Performance

    Participants will be assessed for anaerobic performance with the completion of a quick feet agility test. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  19. Change in Physical Performance - Upper Body Strength Performance

    Participants will be assessed for upper body strength performance with the completion of a handgrip strength test. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  20. Change in Physical Performance - Lower Body Power Performance

    Participants will be assessed for lower body power performance with the completion of a vertical jump test. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  21. Change in Physical Performance - Lower Body Kinematic Performance

    Participants will be assessed for lower body kinematic performance with the completion of the Landing Error Scoring System (LESS) Test. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  22. Change in Physical Performance - Balance Performance

    Participants will be assessed for balance performance with the completion of the Balance Error Scoring System (BESS) Test. This test is part of a larger physical performance battery test which should take approximately 30 minutes for completion

    Measured: Measurements completed immediately after the cognitive battery performed during the Heat Tolerance Test 2 (days 6 and 13) both before and immediately after heat acclimation

  23. Change in Musculoskeletal Gene and Protein Expression

    Musculoskeletal tissue samples will be collected for analysis via RNA-seq

    Measured: Measurement completed after the performance of an exercise-heat stress bout and physical performance battery (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  24. Change in Musculoskeletal Fiber-Typing

    Musculoskeletal tissue samples will be collected for fiber-type analysis via immunohistochemical procedures

    Measured: Measurement completed after the performance of an exercise-heat stress bout and physical performance battery (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  25. Change in Musculoskeletal Mitochondrial Function

    Musculoskeletal tissue samples will be collected for analysis of mitochondrial function

    Measured: Measurement completed after the performance of an exercise-heat stress bout and physical performance battery (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  26. Change in Subcutaneous Abdominal Tissue (SCAAT) Lipolysis Rate

    SCAAT lipolysis rate (interstitial glycerol and ethanol output:input) will be collected and assessed for fat mobilization and subcutaneous adipose tissue blood flow during exercise-heat stress bouts

    Measured: Measurement completed after the performance of an exercise-heat stress bout and physical performance battery (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  27. Change in Resting Energy Expenditure and Macronutrient Oxidation

    Participant resting energy expenditure, fat oxidation, and carbohydrate oxidation will be assessed via indirect calorimetry for the measurement of respiratory quotient and respiratory exchange ratio

    Measured: Measurement completed after the performance of an exercise-heat stress bout and physical performance battery (Heat Tolerance Test 2 - days 6 and 13) both before and immediately after heat acclimation

  28. Change in Circulatory Indicators of Lipid Metabolism - NEFAs

    Blood samples will be collected and assessed for the expression of lipid metabolism biomarker Non-Essential Fatty Acids (NEFAs)

    Measured: Throughout study completion, an average of 14 days

  29. Change in Circulatory Indicators of Lipid Metabolism - Insulin

    Blood samples will be collected and assessed for the expression of lipid metabolism biomarker Insulin

    Measured: Throughout study completion, an average of 14 days

  30. Change in Circulatory Indicators of Lipid Metabolism - IGF-1

    Blood samples will be collected and assessed for the expression of lipid metabolism biomarker Insulin Growth Factor-1 (IGF-1)

    Measured: Throughout study completion, an average of 14 days

  31. Change in Circulatory Indicators of Stress - Epinephrine

    Blood samples will be collected and assessed for the expression of physiological stress biomarker Epinephrine

    Measured: Throughout study completion, an average of 14 days

  32. Change in Circulatory Indicators of Stress - Norepinephrine

    Blood samples will be collected and assessed for the expression of physiological stress biomarker Norepinephrine

    Measured: Throughout study completion, an average of 14 days

  33. Change in Circulatory Indicators of Stress - Cortisol

    Blood samples will be collected and assessed for the expression of physiological stress biomarker Cortisol

    Measured: Throughout study completion, an average of 14 days

  34. Change in Circulatory RNA Content

    Blood samples will be collected and assessed for intracellular RNA content

    Measured: Throughout study completion, an average of 14 days

  35. Change in Circulatory Indicators of Inflammation - IL-1B

    Blood samples will be collected and assessed for the expression of inflammatory biomarker IL-1B

    Measured: Measurement completed during the completion of exercise-heat stress bouts (Heat Tolerance Tests 1 [days 5 and 12] and 2 [days 6 and 13]) both before and immediately after heat acclimation

  36. Change in Circulatory Indicators of Inflammation - TNF-a

    Blood samples will be collected and assessed for the expression of inflammatory biomarker TNF-a

    Measured: Measurement completed during the completion of exercise-heat stress bouts (Heat Tolerance Tests 1 [days 5 and 12] and 2 [days 6 and 13]) both before and immediately after heat acclimation

  37. Change in Circulatory Indicators of Inflammation - IFN-gamma

    Blood samples will be collected and assessed for the expression of inflammatory biomarker IFN-gamma

    Measured: Measurement completed during the completion of exercise-heat stress bouts (Heat Tolerance Tests 1 [days 5 and 12] and 2 [days 6 and 13]) both before and immediately after heat acclimation

  38. Change in Gut Microbiome Diversity

    Stool samples will be collected and assessed for the impact of gut microbiome diversity on heat intolerance

    Measured: Measurement completed prior to the completion of an exercise-heat stress bout (Heat Tolerance Test 2) both before and after heat acclimation

  39. Change in Saliva Metabolite Expression

    Saliva samples will be collected and assessed for metabolite expression

    Measured: Measurement completed during each exercise-heat stress bout (Heat Tolerance Tests 1 and 2) both before and after heat acclimation as well as the final heat acclimation session (HA5)

  40. Change in Thermal Sensation

    0-8 Scale (cold to hot) that indicated how cold or hot the participant feels. 0 = extremely cold, 8 = extremely hot

    Measured: Through study completion, an average of 14 days

  41. Change in Recovery

    Participants will be provided a WHOOP strap after the completion of their baseline visit and will be instructed on how to download the associated application and use of the device. The WHOOP device will be used to provide data on sleep quality and quantity, strain, and recovery

    Measured: Throughout study completion, an average of 14 days

Secondary outcomes (12)
  1. Change in Perception of Fatigue

    0-10 (no fatigue to extreme fatigue), scale indicates how fatigued the participant feels. High score indicates more fatigue (negative outcome)

    Measured: Throughout study completion, an average of 14 days

  2. Change in Perception of Thirst

    0-9 (no thirst to extreme thirst), scale that indicates how thirsty the subject feels, a higher score is considered a negative outcome (more thirsty)

    Measured: Throughout study completion, an average of 14 days

  3. Change in Environmental Perception

    Scale to assess participant perception of the environmental conditions, measurement scale identified as the modified environmental symptoms questionnaire (ESQ) which includes a minimum scale of "Not at all" and a maximum scale of "Extreme". Outcomes are considered worse when associated with greater extremes in documented answers

    Measured: Throughout study completion, an average of 14 days

  4. Change in Rating of Perceived Exertion

    6-20 scale to assess participant perceived exertion levels (how hard they are working) during exercise-heat stress bouts. A greater score indicates greater levels of exertion.

    Measured: Throughout study completion, an average of 14 days

  5. Change in Sleep Quality

    Scale to assess participant sleep habits including quantity and quality, measurement scale identified as the Kalinska sleep diary (KSD) which is a 9-point scale with increasing severity from 1 (extremely alert) to 9 (extremely sleepy - fighting sleep)

    Measured: Throughout study completion, an average of 14 days

  6. Change in Body Mass

    Participants will have nude body weight (kg) assessed at the beginning and end of each testing session

    Measured: Throughout study completion, an average of 14 days

  7. Change in Reproductive Hormone State - Estradiol

    Blood plasma samples will be collected for the measurement of circulating estradiol

    Measured: Throughout study completion, an average of 14 days

  8. Change in Reproductive Hormone State - Progesterone

    Blood plasma samples will be collected for the measurement of circulating progesterone

    Measured: Throughout study completion, an average of 14 days

  9. Change in Reproductive Hormone State - Testosterone

    Blood plasma samples will be collected for the measurement of circulating testosterone

    Measured: Throughout study completion, an average of 14 days

  10. Change in Reproductive Hormone State - LH

    Blood plasma samples will be collected for the measurement of circulating luteinizing hormone (LH)

    Measured: Throughout study completion, an average of 14 days

  11. Change in Reproductive Hormone State - FSH

    Blood plasma samples will be collected for the measurement of circulating follicle stimulating hormone (FSH)

    Measured: Throughout study completion, an average of 14 days

  12. Change in Cardiovascular Response - Blood Pressure

    Blood pressure will be measured manually prior to each testing session with the documentation of systolic and diastolic measurements

    Measured: Throughout study completion, an average of 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jan 2023
  2. Study start16 Sep 2021
  3. Primary completion17 Apr 2024
  4. Study completion17 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will consist of both male and female subjects who will be exposed to similar bouts of exertional heat stress. Analysis will be completed to assess for potential sex-based differences in outcomes measured (male vs. female). Participants (both male and female) who opt-in for antioxidant berry supplementation will be assigned to a subgroup parallel study model where subjects will be exposed to similar bouts of exertional heat stress while consuming either the antioxidant or placebo supplement.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
108 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05678738
Sponsor's protocol ID
H21-0108
Other IDs
BA200299
Acronym
ATHENA
Status last verified
Sep 2025
First submitted
16 Dec 2022
Last updated
11 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Antioxidant Berry Supplementation and Acute and Chronic Exercise-Heat Stress in people with Heat Intolerance and Heat Stress, run by University of Connecticut at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 19 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Rectal Temperature at Rest (time frame: Through study completion, an average of 14 days). The study lists 41 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in